We are live on ! Find out more
ACA

Arena Capital Advisors Portfolio holdings

AUM $208M
1-Year Est. Return 11.42%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+11.42%
3 Year Est. Return
+124.07%
5 Year Est. Return
+150.35%
10 Year Est. Return
AUM
$329M
AUM Growth
-$66.5M
Cap. Flow
-$67.7M
Cap. Flow %
-20.57%
Top 10 Hldgs %
37.47%
Holding
288
New
6
Increased
3
Reduced
84
Closed
31

Sector Composition

Rank Sector Weight
1 Financials 90.58%
2 Industrials 2.54%
3 Healthcare 2.32%
4 Materials 1.5%
5 Technology 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALVOW icon
126
Alvotech Warrant
ALVOW
$58K 0.02%
82,967
EBAC
127
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
$57K 0.02%
5,717
LCAHW
128
DELISTED
Landcadia Holdings IV, Inc. Warrant
LCAHW
$56K 0.02%
317,468
VLATW
129
DELISTED
Valor Latitude Acquisition Corp. Warrant
VLATW
$46K 0.01%
366,663
-293,332
-44% -$33.9K
TLSI icon
130
TriSalus Life Sciences
TLSI
$345M
$43K 0.01%
4,287
TBLA icon
131
Taboola.com
TBLA
$1.11B
$41K 0.01%
22,387
-110,000
-83% -$283K
SUNL.WS
132
DELISTED
Sunlight Financial Holdings, Inc. Warrants, exercisable for 1/20th of a share of Class A Common Stock at an exercise price of $230.00
SUNL.WS
$41K 0.01%
297,835
HCII
133
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
$41K 0.01%
4,192
LAAAW
134
DELISTED
Lakeshore Acquisition I Corp. Warrant
LAAAW
$37K 0.01%
187,500
HMCOW
135
DELISTED
HumanCo Acquisition Corp. Warrant
HMCOW
$37K 0.01%
440,090
ALTUW
136
DELISTED
Altitude Acquisition Corp Warrant
ALTUW
$32K 0.01%
500,000
SKYAW
137
DELISTED
Skydeck Acquisition Corp. Warrants
SKYAW
$31K 0.01%
270,252
-36,833
-12% -$5.8K
JUGGW
138
DELISTED
Jaws Juggernaut Acquisition Corporation Warrant
JUGGW
$29K 0.01%
138,159
-13,412
-9% -$3.3K
AUROW
139
Aurora Innovation Warrant
AUROW
$370M
$28K 0.01%
59,469
-29,748
-33% -$12.9K
MSDAW
140
DELISTED
MSD Acquisition Corp. Warrant
MSDAW
$28K 0.01%
209,781
-40,000
-16% -$8.79K
SNAX
141
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$27K 0.01%
3,333
GROV.WS
142
DELISTED
Grove Collaborative Holdings, Inc. Each whole warrant is exercisable for one-fifth of a share of Class A Common Stock at an exercise price of $57.50
GROV.WS
$25K 0.01%
99,616
ROIVW
143
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$23K 0.01%
59,775
OSTRW
144
DELISTED
Oyster Enterprises Acquisition Corp. Warrant
OSTRW
$21K 0.01%
130,000
ORIAW
145
DELISTED
Orion Biotech Opportunities Corp. Warrant
ORIAW
$20K 0.01%
111,314
MOBXW icon
146
Mobix Labs Warrants
MOBXW
$752K
$17K 0.01%
375,000
CZOO.WS
147
DELISTED
Cazoo Group Ltd Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CZOO.WS
$17K 0.01%
312,832
JWSM.WS
148
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$16K ﹤0.01%
160,019
-62,052
-28% -$10.1K
REVHW
149
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Warrant.
REVHW
$16K ﹤0.01%
378,272
-40,000
-10% -$6.17K
SHCRW
150
DELISTED
Sharecare, Inc. Warrant
SHCRW
$15K ﹤0.01%
63,498

Similar funds

Arena Capital Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Arena Capital Advisors held 288 positions worth $329M, down 17% from $396M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arena Capital Advisors withdrew a net $67.7M in Q3 2022, closing 31 positions and reducing 84 holdings. Its most notable exit was ProKidney, an estimated $11.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 91% of assets, up from 82% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Arena Capital Advisors opened a new position in Vector Acquisition Corporation II Class A Ordinary Shares worth $2.97M.

  • Arena Capital Advisors's largest Q3 2022 buy was Vector Acquisition Corporation II Class A Ordinary Shares: 300,000 shares worth $2.97M.
  • Arena Capital Advisors added most to VectoIQ Acquisition Corp. II Class A Common Stock in Q3 2022, an estimated $3.89M increase.
  • Arena Capital Advisors's biggest Q3 2022 reduction was G Squared Ascend I Inc., cutting an estimated $2.97M.
  • Arena Capital Advisors fully exited ProKidney in Q3 2022, selling an estimated $11.7M.
  • Arena Capital Advisors's ten largest holdings make up 37% of its $329M portfolio in Q3 2022.
  • Arena Capital Advisors opened 6 new positions and closed 31 in Q3 2022.
  • Arena Capital Advisors's portfolio value fell 17% quarter-over-quarter to $329M.

Based on Arena Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.